Key result
Low-dose L-NAME treatment reduced mortality and the severity of heart failure and myocardial necrosis in a murine model of coxsackievirus B3-induced myocarditis.
Why the study?
Does low-dose L-NAME improve survival and decrease myocardial injury in a murine model of coxsackievirus B3-induced myocarditis?
Does low-dose L-NAME improve survival and decrease myocardial injury in a murine model of coxsackievirus B3-induced myocarditis?
Inhibition of NO synthesis with low-dose L-NAME improves survival and reduces myocardial injury in a murine model of viral myocarditis, highlighting the pathogenic role of NO.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for NO inhibition in viral myocarditis; leaves open clinical translation pending human trials.
Recent reports demonstrated the expression of inducible-type NO synthase in the heart of viral myocarditis. Since NO has multiple biological actions, a substantial amount of NO produced in the diseased heart may act either as a cytotoxic or as a cytoprotective molecule in the process of myocarditis. In the present study, we examined the effect of inhibition of NO synthesis on the mortality and the extent of myocardial injury in a murine model of coxsackievirus B3-induced myocarditis. We fed the infected mice drinking water containing a relatively low concentration (0.37 mmol/L) of N omega-nitro-L-arginine methyl ester (L-NAME) for 14 days after virus inoculation. This dose of L-NAME did not change virus titers in the heart. However, L-NAME-fed mice showed a significant reduction in mortality compared with those fed normal drinking water (nontreated mice). On the contrary, mice given a higher concentration of L-NAME (3.7 mmol/L) exhibited increased mortality. In addition, mice fed a low concentration of L-NAME showed reductions in the severity of heart failure and in the area of myocardial necrosis. Although systemic blood pressure was reduced in nontreated mice, in mice fed a low concentration of L-NAME, it was maintained at a level similar to that in uninfected control mice, L-NAME-treated mice also exhibited a reduction in the degree of inflammatory cell infiltration associated with decreased production of tissue prostaglandin E2 levels in the heart compared with nontreated mice. Therefore, NO is likely to be involved in the pathogenic mechanisms of myocardial injury and resultant cardiac dysfunction in a murine model of coxsackievirus B3-induced viral myocarditis.
No takes yet. Share an insight, caveat, or question.
Mikami et al. (1997) studied Coxsackievirus B3-induced viral myocarditis. N omega-nitro-L-arginine methyl ester (L-NAME) vs. Normal drinking water was evaluated on Mortality and extent of myocardial injury. Low-dose L-NAME treatment reduced mortality and the severity of heart failure and myocardial necrosis in a murine model of coxsackievirus B3-induced myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: